PharmaNest, based in Princeton, NJ, is a cutting-edge company specializing in advanced digital pathology image analysis methods for the quantification of fibrosis and associated features. Their flagship product, FibroNest, is a high-resolution, single-fiber AI technology that offers accurate and efficient phenotypic quantification of fibrosis across various tissues and conditions. With a strong focus on translational research and validation, PharmaNest's innovative solutions cater to both pre-clinical and clinical pharmaceutical drug development projects.
Utilizing FibroNest, PharmaNest provides comprehensive services for the quantification of fibrosis phenotypes from digital images of stained slides, making it an invaluable tool for researchers and pharmaceutical companies. The company's expertise extends to a wide range of fibrotic conditions, including liver, lung, kidney, and skin, ensuring the applicability of their technology across multiple areas of study. With a commitment to excellence and continuous improvement, PharmaNest is at the forefront of revolutionizing fibrosis research and contributing to advancements in the field of pathology.
Generated from the website
